Fenofibrate and atorvastatin in patients with combined hyperlipidemia and dense low density lipoproteins

被引：0
|
作者：
Weltzien, P
Winkler, K
Friedrich, I
Schmitz, H
Hauck, P
Hoffmann, M
Baumstark, M
Wieland, H
März, W
机构：
[1] Fournier Pharma GMBH, Dept Med, Sulzbach, Germany
[2] Univ Freiburg, Dept Med, D-7800 Freiburg, Germany
来源：
DIABETOLOGIA | 2002年 / 45卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1208
引用
收藏
页码：A389 / A389
页数：1
相关论文
共 50 条
  • [1] Additive beneficial effects of fenofibrate combined with atorvastatin in the treatment of patients with combined hyperlipidemia
    Koh, KK
    Han, SH
    Quon, MJ
    Chung, WJ
    Shin, MS
    Ahn, TH
    Choi, IS
    Shin, EK
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (03) : 394A - 394A
  • [2] Qualitative effect of fenofibrate and quantitative effect of atorvastatin on LDL profile in combined hyperlipidemia with dense LDL
    Winkler, K
    Weltzien, P
    Friedrich, I
    Schmitz, H
    Nickell, HH
    Hoffmann, MM
    Baumstark, MW
    Wieland, H
    März, W
    [J]. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2004, 112 (05) : 241 - 247
  • [3] Additive beneficial effects of fenofibrate combined with atorvastatin in the treatment of combined hyperlipidemia
    Koh, KK
    Quon, MJ
    Han, SH
    Chung, WJ
    Ahn, JY
    Seo, YH
    Choi, IS
    Shin, EK
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (10) : 1649 - 1653
  • [4] Effect of atorvastatin and fenofibrate on autonomic tone in subjects with combined hyperlipidemia
    Melenovsky, V
    Wichterle, D
    Simek, J
    Malik, J
    Haas, T
    Ceska, R
    Malik, M
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2003, 92 (03): : 337 - 341
  • [5] EFFECTS OF FENOFIBRATE ON PLASMA-LIPOPROTEINS IN HYPERCHOLESTEROLEMIA AND COMBINED HYPERLIPIDEMIA
    KNOPP, RH
    BROWN, V
    DUJOVNE, CA
    FARQUHAR, JW
    FELDMAN, EB
    GOLDBERG, AC
    GRUNDY, SM
    LASSER, NL
    MELLIES, MJ
    PALMER, RH
    SAMUEL, P
    SCHONFELD, G
    SUPERKO, HR
    [J]. AMERICAN JOURNAL OF MEDICINE, 1987, 83 (5B): : 50 - 59
  • [6] Effects of atorvastatin on fasting and postprandial plasma lipoproteins in postinfarction patients with combined hyperlipidemia
    Boquist, S
    Karpe, F
    Danell-Toverud, K
    Hamsten, A
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 35 (02) : 315A - 315A
  • [7] Effects of low doses of atorvastatin in patients with familial combined hyperlipidemia
    Bottazzo, S
    Severi, G
    Fazzin, G
    [J]. ATHEROSCLEROSIS, 1998, 138 : S8 - S8
  • [8] Combination therapy of low-dose atorvastatin and fenofibrate in mixed hyperlipidemia
    Chatley, P.
    Badyal, D. K.
    Calton, R.
    Khosla, P. P.
    [J]. METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY, 2007, 29 (03): : 217 - 221
  • [9] Familial combined hyperlipidemia is associated with enhanced oxidative stress: Effect of atorvastatin and fenofibrate
    Micheletta, F
    Natoli, S
    Montali, A
    Fioretti, F
    Arca, M
    Iuliano, L
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2004, 24 (05) : E41 - E41
  • [10] Atorvastatin and micronized fenofibrate alone and in combination in type 2 diabetes with combined hyperlipidemia
    Athyros, VG
    Papageorgiou, AA
    Athyrou, VV
    Demitriadis, DS
    Kontopoulos, AG
    [J]. DIABETES CARE, 2002, 25 (07) : 1198 - 1202
12345